# A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients

> **NCT00406848** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 370 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** duloxetine hydrochloride
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00406848
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-11
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2010-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406848, "A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00406848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*